CR9927A - Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden - Google Patents

Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden

Info

Publication number
CR9927A
CR9927A CR9927A CR9927A CR9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A CR 9927 A CR9927 A CR 9927A
Authority
CR
Costa Rica
Prior art keywords
understand
preparation process
therapeutic compositions
indolizine derivatives
radical
Prior art date
Application number
CR9927A
Other languages
English (en)
Inventor
Gautier Patrick
Marchionni David
Roccon Alain
Tonnerre Bernard
Wagnon Jean
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027751&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR9927A publication Critical patent/CR9927A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Derivados de indolizina de formula general (I) en la que, X representa un radical -(CH2)n- siendo n un numero entero que va de 1 a 6, o un grupo de formula CH2-Z-(CH2)2-, en la que Z representa un grupo O (CH2)m- en la que m es un numero entero que va de 0 a 3, R1 representa un radical alquilo C1-C8 lineal, ramificado o ciclico; Am representa un grupo NR3R4 en el que R3 y R4 son identicos o diferentes y representan de manera independiente el uno del otro -un atomo de hidrogeno, -un radical alquilo C1-C6 lineal, ramificado o ciclico, o C1-C3 sustituido con un radical cicloalquilo C3-C6- o un radical (CH2)-O-B, en el que B representa un atomo de nitrogeno o un radical alquilo (CH2)k.
CR9927A 2005-11-23 2008-04-25 Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden CR9927A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511849A FR2893616B1 (fr) 2005-11-23 2005-11-23 Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant

Publications (1)

Publication Number Publication Date
CR9927A true CR9927A (es) 2008-10-06

Family

ID=37027751

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9927A CR9927A (es) 2005-11-23 2008-04-25 Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden

Country Status (33)

Country Link
US (1) US7799799B2 (es)
EP (1) EP1957490B1 (es)
JP (1) JP5372514B2 (es)
KR (1) KR101419066B1 (es)
CN (1) CN101312973B (es)
AR (1) AR058208A1 (es)
AT (1) ATE454386T1 (es)
AU (1) AU2006316381B2 (es)
BR (1) BRPI0618975A2 (es)
CA (1) CA2629738C (es)
CR (1) CR9927A (es)
CY (1) CY1110623T1 (es)
DE (1) DE602006011649D1 (es)
DK (1) DK1957490T3 (es)
DO (1) DOP2006000254A (es)
EA (1) EA014158B1 (es)
EC (1) ECSP088455A (es)
ES (1) ES2338922T3 (es)
FR (1) FR2893616B1 (es)
GT (1) GT200600489A (es)
HR (1) HRP20100158T1 (es)
IL (1) IL190861A (es)
MA (1) MA30055B1 (es)
NO (1) NO20082589L (es)
PE (1) PE20071083A1 (es)
PL (1) PL1957490T3 (es)
PT (1) PT1957490E (es)
SI (1) SI1957490T1 (es)
TN (1) TNSN08162A1 (es)
TW (1) TW200738705A (es)
UY (1) UY29965A1 (es)
WO (1) WO2007060318A1 (es)
ZA (1) ZA200803565B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
FR2962438B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'indolizines, procedes de preparation et application en therapeutique
CN103360390B (zh) * 2013-07-23 2015-06-17 东南大学 中氮茚甲酰甲基对甲磺酰胺苯乙胺衍生物及其医药用途
CN110156776A (zh) * 2019-04-30 2019-08-23 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种c-3芳甲酰基吲嗪类化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5334716A (en) * 1991-06-17 1994-08-02 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic derivatives
US6593322B1 (en) * 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
FR2813306B1 (fr) * 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant

Also Published As

Publication number Publication date
DE602006011649D1 (de) 2010-02-25
ZA200803565B (en) 2009-12-30
BRPI0618975A2 (pt) 2011-09-20
ECSP088455A (es) 2008-06-30
EA014158B1 (ru) 2010-10-29
EA200801400A1 (ru) 2008-10-30
AU2006316381A1 (en) 2007-05-31
CA2629738C (fr) 2014-09-23
HK1126198A1 (en) 2009-08-28
WO2007060318A1 (fr) 2007-05-31
EP1957490A1 (fr) 2008-08-20
JP5372514B2 (ja) 2013-12-18
IL190861A0 (en) 2008-11-03
JP2009516725A (ja) 2009-04-23
CY1110623T1 (el) 2015-04-29
ATE454386T1 (de) 2010-01-15
EP1957490B1 (fr) 2010-01-06
FR2893616B1 (fr) 2008-01-04
KR20080072000A (ko) 2008-08-05
IL190861A (en) 2013-02-28
AU2006316381B2 (en) 2012-05-31
UY29965A1 (es) 2007-06-29
US20080287485A1 (en) 2008-11-20
PL1957490T3 (pl) 2010-07-30
GT200600489A (es) 2007-09-19
DK1957490T3 (da) 2010-05-10
TW200738705A (en) 2007-10-16
KR101419066B1 (ko) 2014-07-11
PT1957490E (pt) 2010-03-29
HRP20100158T1 (hr) 2010-05-31
CN101312973B (zh) 2011-12-28
US7799799B2 (en) 2010-09-21
MA30055B1 (fr) 2008-12-01
CN101312973A (zh) 2008-11-26
DOP2006000254A (es) 2007-06-15
PE20071083A1 (es) 2007-12-03
SI1957490T1 (sl) 2010-04-30
AR058208A1 (es) 2008-01-23
NO20082589L (no) 2008-06-10
CA2629738A1 (fr) 2007-05-31
FR2893616A1 (fr) 2007-05-25
ES2338922T3 (es) 2010-05-13
TNSN08162A1 (en) 2009-10-30

Similar Documents

Publication Publication Date Title
AR068055A1 (es) Derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y su utilizacion principalmente como inhibidores de met
CR9927A (es) Derivados nuevos de indolizina, su proceso de preparacion y las composiciones terapeuticas que los comprenden
AR106943A2 (es) Compuestos de isoindolina y composiciones farmacéuticas de los mismos
NO20091562L (no) 2-aryl-6-fenylimidazol{1,2-alpha}pyridin derivater, femstilling derav samt terapeutisk anvendelse derav
EA202091530A1 (ru) Диазаиндольные соединения
EP4186506A4 (en) Composition containing arylamide derivative
ES2530497T3 (es) Aditivo para mezclas de materiales de construcción que contienen agente licuante
AR075249A1 (es) Derivados de 6-(6-o-sustituido-triazolopiridazina-sulfanil) benzotiazoles y bencimidazoles, metodo de preparacion de los mismos e intermediarios de dicha sintesis, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer, artritis, alergias y otras enfermedades.
PE20080688A1 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas como antagonistas de trpv1 y su preparacion
NI201000134A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX2020006290A (es) Dinucleotidos ciclicos como agonistas de sting.
TW201129552A (en) Salt and photoresist composition containing the same
BR112018001816A2 (pt) “análogos de adamantil ureias como inibidores solúveis da epóxido hidrolase
CO6230990A2 (es) Nuevos derivados triciclicos su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
MX389581B (es) Compuestos que contienen nitrogeno sustituido.
ATE422163T1 (de) Absorbierbare alpha-cyanacrylat-zusammensetzungen
NO20061872L (no) Disulfid, sulfid, sulfoksid, og sulfoderivater av sykliske sukkere og anvendelse derav
PE20070097A1 (es) Agonistas del receptor de niacina y composiciones que contienen tales compuestos
AR066955A1 (es) Derivados de 7- alquinil -1,8- naftiridonas, su preparacion y su aplicacion en terapeutica
ES2540327T3 (es) Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos
AR082962A1 (es) Derivados de quinoxalina y composiciones farmaceuticas
ES2234825T3 (es) Nuevos derivados heterociclicos o bencenicos del acido lipoico, su preparacion y su aplicacion como medicamentos.
CR8735A (es) Derivados de tetrahidroisoquinolinilsulfonamidas, su preparacion y su utilizacion en terapeutica
CO5200761A1 (es) Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos
AR031662A1 (es) Nuevos derivados biciclicos de aminopirazinonas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y su utilizacion como inhibidores de proteasas de serina relacionadas con la tripsina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)